We are live on ! Find out more
SSIA

Spero-Smith Investment Advisers Portfolio holdings

AUM $74.5M
1-Year Est. Return 12.27%
This Fund
S&P 500
This Quarter Est. Return
-0.11%
1 Year Est. Return
+12.27%
3 Year Est. Return
+31.25%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$86.1M
AUM Growth
-$2.36M
Cap. Flow
-$1.94M
Cap. Flow %
-2.25%
Top 10 Hldgs %
46.11%
Holding
45
New
3
Increased
6
Reduced
29
Closed
1

Top Buys

Rank Stock Value
1
UL icon
Unilever
UL
+$1.9M
2
JNJ icon
Johnson & Johnson
JNJ
+$219K
3
AMGN icon
Amgen
AMGN
+$199K
4
AAPL icon
Apple
AAPL
+$72.5K
5
BP icon
BP
BP
+$27.2K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$1.25M
2
HAR
Harman International Industries
HAR
+$1.02M
3
TMO icon
Thermo Fisher Scientific
TMO
+$882K
4
WOR icon
Worthington Enterprises
WOR
+$224K
5
INTC icon
Intel
INTC
+$79.6K

Sector Composition

Rank Sector Weight
1 Energy 23.69%
2 Technology 21.37%
3 Healthcare 20.9%
4 Communication Services 10.2%
5 Financials 9.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XOM icon
1
ExxonMobil
XOM
$650B
$13.6M 15.82%
144,905
-541
-0.4% -$53.9K
GOOG icon
2
Alphabet (Google) Class C
GOOG
$4.11T
$3.36M 3.9%
115,536
+641
+0.6% +$18.5K
FISV
3
Fiserv Inc
FISV
$29.7B
$3.13M 3.63%
96,798
-2,000
-2% -$63.2K
DHR icon
4
Danaher
DHR
$138B
$3.1M 3.6%
60,803
-519
-0.8% -$26.7K
MCK icon
5
McKesson
MCK
$104B
$2.89M 3.36%
14,869
-265
-2% -$51K
WFC icon
6
Wells Fargo
WFC
$254B
$2.87M 3.33%
55,380
-796
-1% -$40.9K
NVS icon
7
Novartis
NVS
$302B
$2.86M 3.32%
33,884
-597
-2% -$48.3K
MSFT icon
8
Microsoft
MSFT
$2.9T
$2.68M 3.11%
57,769
-1,070
-2% -$47.7K
CVS icon
9
CVS Health
CVS
$135B
$2.67M 3.09%
33,490
-656
-2% -$51.7K
CERN
10
DELISTED
Cerner Corp
CERN
$2.54M 2.95%
42,630
-600
-1% -$33.7K
INTC icon
11
Intel
INTC
$413B
$2.53M 2.93%
72,564
-2,351
-3% -$79.6K
SNI
12
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
$2.48M 2.88%
31,734
-830
-3% -$66.8K
COP icon
13
ConocoPhillips
COP
$144B
$2.44M 2.83%
31,881
-503
-2% -$41.2K
VTRS icon
14
Viatris
VTRS
$20.8B
$2.31M 2.68%
50,761
-970
-2% -$47.2K
HBAN icon
15
Huntington Bancshares
HBAN
$34B
$2.3M 2.67%
236,076
-4,360
-2% -$42.7K
ACN icon
16
Accenture
ACN
$106B
$2.27M 2.63%
27,868
-540
-2% -$43.3K
VZ icon
17
Verizon
VZ
$197B
$2.23M 2.59%
44,670
-116
-0.3% -$5.77K
EMC
18
DELISTED
EMC CORPORATION
EMC
$2.17M 2.52%
74,300
-1,725
-2% -$49.8K
SRCL
19
DELISTED
Stericycle Inc
SRCL
$2.12M 2.46%
18,195
-335
-2% -$39.6K
IBM icon
20
IBM
IBM
$213B
$1.96M 2.27%
10,800
-256
-2% -$46.6K
TMO icon
21
Thermo Fisher Scientific
TMO
$214B
$1.88M 2.18%
15,434
-7,250
-32% -$882K
TRV icon
22
Travelers Companies
TRV
$81.1B
$1.87M 2.18%
19,955
-400
-2% -$37.3K
CELG
23
DELISTED
Celgene Corp
CELG
$1.86M 2.16%
19,645
-13,845
-41% -$1.25M
UL icon
24
Unilever
UL
$142B
$1.82M 2.11%
+38,548
New +$1.9M
ANSS
25
DELISTED
Ansys
ANSS
$1.73M 2.01%
22,865
-330
-1% -$25.9K
1
2

Similar funds

TC
Talkot Capital Sausalito, California $73.7M AUM 8.5% 1-Year Est. Return
BCM
Boyle Capital Management West Des Moines, Iowa $73.5M AUM 14.12% 1-Year Est. Return
PPCM
PW Partners Capital Management Chicago, Illinois $76.7M AUM 8.73% 1-Year Est. Return
LCP
LeVasseur Capital Partners Newport Beach, California $71.4M AUM 0.52% 1-Year Est. Return
EDRI
Edmond de Rothschild (Italia) Milano, Italy $80.7M AUM 13.11% 1-Year Est. Return
TGI
Tradewinds Global Investors Los Angeles, California $81.3M AUM 9.21% 1-Year Est. Return
SVP
Springbank Value Partners Hampton Bays, New York $65.5M AUM 35.56% 1-Year Est. Return
IACCA
IDG-Accel China Capital Associates Central, Hong Kong $83.9M AUM 23.73% 1-Year Est. Return

Spero-Smith Investment Advisers's Q3 2014 Portfolio in Review

As of Q3 2014, Spero-Smith Investment Advisers held 45 positions worth $86.1M, down 2.7% from $88.5M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Spero-Smith Investment Advisers's Q3 2014 filing shows 3 new, 6 increased, 29 reduced and 1 closed positions. Its largest new stake was Unilever: 38,548 shares worth $1.82M. The largest sale was Celgene Corp, an estimated $1.25M.

By sector, the portfolio is most concentrated in Energy at 24% of assets, down from 25% a quarter earlier, followed by Technology and Healthcare.

  • Spero-Smith Investment Advisers's largest Q3 2014 buy was Unilever: 38,548 shares worth $1.82M.
  • Spero-Smith Investment Advisers added most to Apple in Q3 2014, an estimated $72.5K increase.
  • Spero-Smith Investment Advisers's biggest Q3 2014 reduction was Celgene Corp, cutting an estimated $1.25M.
  • Spero-Smith Investment Advisers fully exited Worthington Enterprises in Q3 2014, selling an estimated $224K.
  • Spero-Smith Investment Advisers's ten largest holdings make up 46% of its $86.1M portfolio in Q3 2014.
  • Spero-Smith Investment Advisers opened 3 new positions and closed 1 in Q3 2014.
  • Spero-Smith Investment Advisers's portfolio value fell 2.7% quarter-over-quarter to $86.1M.

Based on Spero-Smith Investment Advisers's 13F filing for Q3 2014, filed 4 Nov 2014.